Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56+ Cells
Authors:
- 18 April 2012
- journal article
- clinical trial
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 68 (1) , 75-84
Abstract
Problem: Natural killer (NK, CD3− CD56+/CD16+) and NKT‐like cells (CD3+ CD56+/CD16+) activity is considered among the key factors for reproductive success. In the absence of immunological screening, beneficial effects of intravenous immunoglobulin (IVIG) in preventing recurrent reproductive failure (RRF) have not been reported. Here, we analyse the IVIG influence on pregnancy success in women with RRF and circulating NK or/and NKT‐like cells expansion.Method of study: One hundred fifty‐seven women with previous recurrent miscarriage and/or recurrent implantation failure after in vitro fertilization were consecutively studied. Sixty‐four patients with CD56+ cell expansion, no apparent underlying disease and who maintained their desire to conceive were selected. Forty of them received IVIG during pregnancy.Results: Overall, the clinical pregnancy rate for the women under IVIG therapy was 92.5% and the live birth rate was 82.5%. Significantly lower pregnancy and live birth rates (25% and 12.5%, respectively) were observed for the patients with recurrent pregnancy loss and NK/NKT‐like cells expansion without IVIG. After three cycles of IVIG, NK cell percentages decreased significantly and these values persisted throughout gestation.Conclusion: Intravenous immunoglobulin therapy for women with RRF and NK or NKT‐like cell expansion was a safe and beneficial therapeutic strategy that associated with high clinical pregnancy and live birth rates.Keywords
This publication has 35 references indexed in Scilit:
- Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulinJournal of Allergy and Clinical Immunology, 2011
- Recurrent MiscarriageNew England Journal of Medicine, 2010
- Study on the Relationship Between Th17 Cells and Unexplained Recurrent Spontaneous AbortionAmerican Journal of Reproductive Immunology, 2010
- Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trialHuman Reproduction, 2010
- SHORT COMMUNICATION: CD3− CD56+ CD16+ Natural Killer Cells and Improvement of Pregnancy Outcome in IVF/ICSI Failure After Additional IVIG‐TreatmentAmerican Journal of Reproductive Immunology, 2010
- Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”Blood, 2008
- NKT Cells at the Maternal-Fetal InterfaceImmunological Investigations, 2008
- Recurrent miscarriageThe Lancet, 2006
- High Levels of Peripheral Blood NK Cells in Women Suffering from Recurrent Spontaneous Abortion are Reverted from High‐Dose Intravenous ImmunoglobulinsAmerican Journal of Reproductive Immunology, 2006
- Elevated Peripheral Blood Natural Killer Cells Are Effectively Downregulated by Immunoglobulin G Infusion in Women With Recurrent Spontaneous AbortionsAmerican Journal of Reproductive Immunology, 1996